Apoquel and Cytopoint: Where and when to use in your dermatology cases
14 Nov 2024
Platinum Suite - Level 3
In this presentation we closely examine the groundbreaking therapies Apoquel and Cytopoint and their place in effective treatment of canine allergic and atopic dermatitis. We will cover their modes of action and key safety and efficacy studies, as well as pinpoint where and when they can be effectively utilised in the consultation room. We will also look at the importance of considering owner caregiver burden and how these therapies can help to ease this.
Learning Outcomes
-Define and understand owner perspectives and caregiver burden for the pruritic dog.
-Understand the pathophysiology of canine allergic dermatitis and how oclacitinib and lokivetmab work to provide effective therapy.
-Gain clear knowledge of the effective positioning of Apoquel, Apoquel Chewable and Cytopoint in clinical practice.
)
)
)
){kind=logo}
)
){kind=icon}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
){kind=logo}
)
)
){kind=logo}